Record profit masks an earnings quality gap
IOB's ₹1,659.2 Cr net profit jumped 49.3% year-on-year. But dig into the delivery: 81% of that ₹1,353 Cr total came from PSLC commission and loan recovery—non-recurring items. The call reveals an honest operational story: solid momentum offset by sustainability risk.
₹1,659.2 Cr
+49.3% YoY
₹1,353 Cr
81% of headline profit
~₹266 Cr
ex non-recurring items
On the surface, IOB's first quarter looks like a blowout. Net profit at an all-time high of ₹1,659.2 Cr, up nearly 50% year-on-year, delivered on credit growth 22.75% and NIM holding steady at 3.37%. Asset quality best-in-cycle. Management delivered on guidance. Yet the market's verdict—day 1 pop of 0.71% faded to a 3.37% drop by day 3—hints that the real story is more muted. The tension between the headline and what's sustainable is the quarter.
Where the ₹1,659 Cr came from
Net interest income grew 34.3% year-on-year, a genuinely strong operational signal. But that income line is draped in non-recurring items. PSLC commission—the regulatory pass-through that sells priority-sector loan certificates to other banks—delivered ₹863 Cr this quarter. Recovery from technically written-off loans: ₹490 Cr. Together, ₹1,353 Cr. That is 81% of the reported ₹1,659.2 Cr profit. Absent those two lines, operating net profit sits closer to ₹266 Cr. Management, when pushed by analyst Ashok Ajmera on the call, defended these items as 'routine, every quarter, integral part of non-interest income, will continue going forward.' The detail matters: the call provided no quantification of PSLC or recovery as a percentage of full-year profit, and no decomposition of how much is truly recurring versus how much rides on the stock of written-off accounts and regulatory PSLC flows.
These are routine, every quarter. NII grew 34.3%, that's the real driver. PSLC and recovery are integral non-interest income and will continue going forward.
All-time high net profit ₹1,659 Cr, 49.3% YoY growth
Delivered exactly ₹1,659.2 Cr, growth confirmed. But 81% (₹1,353 Cr) from PSLC ₹863 Cr + recovery ₹490 Cr.
Supported but qualified
NIM 3.37% global, 3.48% domestic within guidance range
Delivered 3.37% global, 3.48% domestic. Slight beat on 3.3-3.35% guidance, within management confidence.
Supported
Credit growth 22.75% YoY; 13-14% guidance minimum
Delivered ₹3.22 L Cr advances vs ₹2.62 L Cr prior year. Well above conservative baseline; consistent with historical 20%+ average.
Supported
Asset quality best-in-cycle: GNPA 1.33%, slippage 0.06%
Verified: GNPA down 64 bps YoY from 1.97%. Net NPA 0.18%, down 14 bps. Slippage at historic low.
Supported
PSLC and recovery are routine and will continue at current levels
No precedent data, no quantification, no sustainability mechanism disclosed. Management defensive when pressed.
Overstated
What changed on this call
Three strategic shifts emerged. First, credit growth came in at 22.75% year-on-year—well above the 13-14% minimum guidance. Management noted this is the floor, not the ceiling, consistent with the last three years' 20%+ average. Second, IOB took a discipline decision: exited a ₹10,000 Cr corporate account in April that was pricing below 7%, below the 4.7% cost of deposits. The move temporarily dented the corporate loan book (down 10% quarter-on-quarter) but reaffirmed a 'no loss-making business' philosophy; management expects the ₹14,000 Cr pipeline to offset this by year-end, targeting 12-13% FY corporate growth. Third, two international moves: IFSCA licensed the bank for a GIFT City branch 3-4 months ago (operationalizing in ~2 months), with an early-stage target of $500 million book by FY-end. And FCNR deposit mobilization is doubling: ₹4.5 lakh NRI customers, $300 million current target to $600-650 million by September (end of regulatory dispensation). These are not mega-scale but signal a strategic pivot toward retail international expansion and pricing discipline over pure volume.
How the street is positioned
The market's reaction is instructive. The day-1 pop of +0.71% faded sharply: by day 3, the stock had given back the gain and more, down 3.37% from day 1 close. Today at ₹33.88, the stock sits 18.95% below its all-time high of ₹41.8, and below its 20-day, 50-day, and 200-day simple moving averages—a bearish technical picture. The RSI sits at 47.2 (neutral-to-weak). Ownership is ultra-concentrated: Government holds 92.44%, steady quarter-over-quarter. FII have crept to 0.43% (from 0.35% prior Q), and DII hold 4.28%, flat. The volume trend is increasing, but the flow context suggests neither strong conviction buying nor panic selling—instead, a market that bought the headline and sold the detail. That divergence is worth paying attention to.
NII growth 34.3% YoY—genuine core momentum
Credit growth 22.75% YoY, well ahead of 13-14% minimum guidance
Asset quality best-in-cycle: GNPA 1.33%, slippage 0.06%, lowest recent
NIM stable 3.37% global, 3.48% domestic; CASA discipline holding 41%
Corporate pricing discipline: exited ₹10K Cr sub-7% business for principle
81% of PAT (₹1,353 Cr) from PSLC and recovery—non-structural
Management defensive on PSLC/recovery sustainability; no detail provided
SMA 2 uptick ₹500 Cr quarter-on-quarter to ₹4,246 Cr; stress emerging
₹5,000 Cr equity raise Q3-Q4 will dilute the 92.44% government float
West Asia 'looming large'; macro headwind priced in
PSLC + recovery cyclicality and normalization
High₹1,353 Cr (81% of PAT) from these items. If they halve, headline profit drops 40%+. Management's 'routine' claim lacks credibility; no mechanism disclosed for why they persist at current scale.
SMA 2 migration and asset quality inflection
MediumSMA 2 up ₹500 Cr quarter-on-quarter to ₹4,246 Cr. While slippage remains best-in-cycle (0.06%), this signals early-stage stress at portfolio edges. West Asia pressure could accelerate migration.
Rate environment and NIM compression
MediumNIM guidance 3.3-3.4% depends on stable/rising rates and CASA hold at 41%. If rate cuts accelerate or competition for deposits rises, compression risk is real despite management confidence.
₹5,000 Cr equity raise—shareholder dilution
MediumGovernment holds 92.44%; equity raise will dilute minority. Unless government participates pro-rata, EPS dilution to the public float is a given in Q3-Q4.
Corporate book recovery and pipeline traction
Low–MediumManagement exited ₹10K Cr and expects recovery via ₹14K Cr pipeline by year-end (12-13% growth). If pipeline stalls or delays, growth guidance miss.
1 · Q2 organic profit and PSLC/recovery levels
The real test comes when PSLC and recovery roll through a normal quarter. Without an ₹1.35K Cr cushion, what does the organic run-rate look like? Track: (a) PSLC commission as a % of quarterly profit, (b) recovery realization, (c) whether core NII momentum persists.
2 · Corporate loan book recovery and pricing discipline hold
Management claims ₹14K Cr pipeline will offset the ₹10K Cr exit and drive 12-13% FY corporate growth. Watch for: pipeline realization, pricing (yield on corporate), and whether 'no loss-making business' discipline sticks or unwinds if growth slows.
3 · Equity raise timing, method, and government participation
₹5,000 Cr raise approved for Q3-Q4. Will it be QIP, rights, or public offering? Will Government participate pro-rata to avoid EPS dilution to the public float? This determines valuation risk in the next two quarters.
IOB delivered a quarter of solid operational execution on credit, NIM, and asset quality. The bank showed discipline (exiting a loss-making account), strategic thinking (GIFT City, FCNR), and authentic management communication (directly addressing SMA 2, West Asia, PSLC sustainability). But the headline profit is a mirage: 81% of ₹1,659.2 Cr came from one-time and cyclical items. The stock's day-1 pop fading to a day-3 decline is the market reading that gap correctly.
Treat this as a steady execution quarter, not a step-change. The organic profit sits closer to ₹266 Cr (implied, ex PSLC and recovery). The number to track from here is that organic run-rate in Q2 and beyond. Until management quantifies PSLC and recovery sustainability with hard precedent or mechanism, assume they are cyclical. The bull case is real and defensible (NII momentum, asset quality, execution), but it trades at a discount to the headline for good reason. Watch Q2.
Record profit masks earnings quality risk: 81% from PSLC, recovery
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade A
Met/beat prior guidance (14-15% growth, 3.3-3.4% NIM). 11 consecutive quarters of positive growth. Transparent on challenges (SMA 2, West Asia). But earnings quality concerns limit grade from A+ to A.
Optimistic
next 1–2 quarters
Optimistic
multi-year
IOB delivered strong Q1 with 49.3% PAT growth and 22.75% credit growth, beating 14-15% guidance. BUT 81% of ₹1,659 Cr profit (₹1,353 Cr) stems from PSLC commission and written-off recovery—non-recurring items management claims are 'routine' but lack structural foundation. Core NII growth (34.3%) is genuine and operational momentum is solid. Risks: if PSLC/recovery normalize, profit crater 40%+. Capital raise (₹5K Cr) dilution in Q3-Q4 also headwind.
₹8777.6 Cr
Revenue · +18.8% YoY₹1659.2 Cr
Reported PAT · +49.3% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
All-time high quarterly net profit INR 1,659 crores, 49.3% YoY
METDelivered exactly ₹1,659.2 Cr, 49.3% growth confirmed. But 81% (₹1,353 Cr) from PSLC ₹863 Cr + recovery ₹490 Cr
NIM 3.37% global, 3.48% domestic maintained in 3.3-3.35% guidance range
METDelivered 3.37% global (slightly above 3.35%), 3.48% domestic. Slight beat, within management confidence
Credit growth 22.75% YoY, 14-15% prior guidance minimum, last 3 years averaged 22%
METDelivered 22.75% YoY advances growth (₹3,22,132 Cr vs ₹2,62,421 Cr). Guidance was conservative baseline, actual well above
Asset quality improving: GNPA 1.33%, slippage 0.06%, both best-in-cycle
METDelivered GNPA 1.33% (down 64 bps YoY), net NPA 0.18%, slippage 0.06%. Verified correct. Quality is genuinely strong
Will maintain profitability momentum; NII growth 34.30% YoY shows core strength
OVERSTATEDNII growth is real and strong. But headline PAT is inflated by ₹1.35K Cr one-time items. Core operating PAT sustainability questioned
Earnings quality
What changed since the last call
NIM expansion vs prior 3.35% March level
UpgradeDomestic NIM 3.48% (was 3.35% March), global 3.37%. Guided 3.3-3.4%, came in ~3.37%. Slight beat on management confidence in CASA focus + deposit repricing completion
Credit growth rate vs 13-14% guidance
UpgradeActual 22.75% YoY (₹3,22,132 Cr) vs guided 13-14% minimum. Management says this is consistent with 20% over last 3 years; guidance is conservative floor not ceiling
Asset quality trajectory
UpgradeGNPA 1.33% (down 64 bps YoY from 1.97%), net NPA 0.18% (down 14 bps from 0.32%), slippage 0.06% (best-in-cycle). Provisioning buffer strong, ECL provisions ₹2,150 Cr of ₹3,000 Cr requirement already booked
Corporate pricing discipline vs market pressure
NewExited ₹10,000 Cr account in April for sub-7% pricing. Shows willingness to forego growth for quality. Management: 'no loss-making business' philosophy. Temporary 10% QoQ corporate decline, expect 12-13% FY growth
International operations expansion
NewIFSCA GIFT City license received 3-4 months ago, branch coming in 2 months, target $500 million book by FY-end. FCNR mobilization ongoing, ₹4.5 lakh NRI customers, doubling $ deposits to $600M by Sep
The Q&A
Analyst Ashok Ajmera pressed hard on earnings sustainability: whether PSLC (₹863 Cr) + recovery (₹490 Cr) will persist. Management held to script ('routine, every quarter, integral part') but lacked conviction. Sumera Choksi probed NIM/ROA maintenance at current levels; MD confident but noted macro uncertainty (West Asia). No major evasion; Q&A was direct and detailed.
Earnings quality, PSLC sustainability — Ashok Ajmera, Ajcon Global
PartialThese are routine, every quarter. NII grew 34.3% YoY, that's the real driver. PSLC, recovery are integral non-interest income, will continue going forward. Last 8-9 quarters show this pattern
ECLGS preparedness and ECL provisioning — Ashok Ajmera, Ajcon Global
Answered₹3,000 Cr requirement estimated; already provisioned ₹2,150 Cr (₹1,700 Cr till March + ₹400 Cr Q1). Will complete in coming quarters. No intent to take 4-year dispensation, handle in one shot
SMA 2 increase, asset quality trend — Ashok Ajmera, Ajcon Global
AnsweredMostly regularized. Slippage 0.06% (best-in-cycle vs 0.10% March, 0.12% historical). No government guaranteed; CGTMSE/CGFMU coverage in smaller accounts. Asset quality 100% sure
Yield on advances expansion, corporate loan strategy — Ashlesh Sonje, (firm not stated)
AnsweredYield up due to pricing; 54% portfolio MCLR, 37% RLLR-linked. ₹10,000 Cr account exited in April for sub-7% pricing (not matching). 40% covered Q1, rest Q2-4. Pipeline ₹14K Cr, expect 12-13% FY growth
Deposit cost reduction, CASA strategy — Ashlesh Sonje
AnsweredCASA focus aggressive; maintained 41% ratio despite 13-14% total & 17% retail term deposit growth. 6-7% bulk deposit ratio, not aggressive on high-rate deposits. All repricing done 6 months ago
Fee income growth 20% YoY drivers — Ashlesh Sonje
Answered₹476 Cr is exchange, commission, LC, BG, non-fund business, locker rents, demand drafts. Base was low (₹398 Cr last year). No fee structure changes; at sanction, terms fixed, don't change unless rating downgrade
Loan book growth guidance conservatism — Kushal (firm not stated)
AnsweredNot conservative. This will be minimum. Last 3 years grew 22% on average; 13-14% is guidance floor. Actual will exceed if normal conditions persist
NIM, ROE sustainability, digital initiatives — Sumera Choksi (firm not stated)
AnsweredLast 6-8 quarters consistent improvement. Strategy working well. Going forward, same plan with moderation if needed. If smooth, can see growth. NIM 3.3-3.4%, ROA 1.4-1.5% next 2-3 quarters. Digital: 96% transactions digital, 75% onboarding digital, loan approval in 10 mins, locker in 2 mins
GIFT City IFSCA license monetization — Sumera Choksi
AnsweredLicense 3-4 months ago, branch operational in ~2 months. Internal budget target $500 million book by FY-end. Early stage but strategic opportunity
Corporate account exit rationale, pricing discipline — Ashlesh Sonje
AnsweredNo loss-making business, very clear. 22% overall credit growth achieved; pricing doesn't matter if growth is there. Not interested in corporate at sub-7% if cost of deposit is 4.7%. Maximize income at good price matching cost of funds. Asset quality good, slippage minimal. Fundamentals-focused
FCNR deposit mobilization — Ashlesh Sonje
AnsweredMobilized $300 million. 4 overseas centres, 4.5 lakh NRI customers. Target double to $600-650 million by September (dispensation ending). Personal contact, SMS, email outreach ongoing
Capital raise timeline, method (QIP vs public) — Vimal Panchal, Aryan Rana
PartialBoard-approved ₹5,000 Cr. Process of statutory approval ongoing. Expected Q3-Q4, market-dependent. Likely 1-2 or more tranches. Government holds 92.44%; method TBD (QIP likely but public offering option for min public shareholding)
Credit cost guidance full year — Aryan Rana
AnsweredJune quarter credit cost 0.14%. Full year expect 0.35-0.40%. Asset quality trajectory best-in-cycle
Book value per share reconciliation — Aditya Mundra
PartialDTA ₹200 Cr, MTM ₹300 Cr. (Full reconciliation not detailed; partial response)
ROE growth drivers, NIM upside — Aditya Mundra
AnsweredNIM-driven. Both sides (interest income up, expenses down). Will be on same strategy/trend. Product mix depends on geography/requirement, dynamic thing, RAM ~80%, will maintain that level
Guidance
Intend 13-14% assets & liabilities growth minimum
HighActual delivered 22.75% credit growth YoY; claim this is floor not ceiling. Last 3 years averaged 22%
Corporate loan book expect 12-13% FY growth by year-end
MediumAfter ₹10K Cr strategic exit in April, 40% covered Q1, rest recovery expected Q2-4. Pipeline ₹14K Cr sanctioned
NIM to be maintained 3.3-3.4% range full year
HighDelivered 3.37% global June, 3.48% domestic. Strategy: CASA focus (41% ratio), deposit repricing complete, asset yield up 10 bps QoQ
ROA 1.41% delivered; guiding 1.46% by FY-end
HighROE 22.69% (up 369 bps YoY). NIM-driven improvement. Both interest income & cost of funds being managed
GIFT City branch ₹ spend not quantified; target $500M book by FY-end
MediumLicense obtained 3-4 months ago, branch operational in ~2 months. Exploratory stage, small capex allocation expected
Risks the call surfaced
Earnings quality deterioration
High₹1,353 Cr (81%) of ₹1,659 Cr PAT from PSLC commission & written-off recovery. Management claims routine & will continue, but if these halve or don't materialize next quarter, profit drops 40%+. Analyst Ajmera challenged sustainability; MD defensive.
Asset quality inflection risk
MediumSMA 2 increased ₹500 Cr QoQ to ₹4,246 Cr (₹13K Cr total SMA at 4.05%). While slippage ratio 0.06% remains best-in-cycle, the SMA 2 uptick suggests stress emerging at portfolio edges. West Asia headwinds may accelerate this.
Macro headwind and rate pressure
MediumManagement explicitly flags West Asia conflict 'looming large'. While no material impact yet ('individual cases only, not sectoral'), extended conflict could pressure credit demand and/or asset quality. Rate environment: NIM guidance 3.3-3.4% depends on stable/rising rates; if cuts accelerate, compression risk despite CASA discipline.
Corporate loan exit and growth recovery
Low₹10,000 Cr account exited in April due to sub-7% pricing not matching cost of funds. 10% QoQ corporate decline visible, but management confident 40% will recover Q2-4 from ₹14K Cr pipeline. Risk is if recovery slower than expected or pricing environment worsens.
Capital dilution from equity raise
Medium₹5,000 Cr equity raise approved Q3-Q4 execution. Government owns 92.44%; unless rights issue or QIP heavily subscribed by government, minority shareholders will face dilution. Also ₹1,000 Cr Tier 2 bonds may impact leverage profile.
Management
Score 7/10. Direct, data-heavy. Transparently addresses challenges (SMA 2, corporate exit, West Asia). But defensive on earnings quality (PSLC+recovery)—tries to normalize cyclical items as structural. Strong track record: 11 consecutive quarters positive growth, met/beat guidance on credit (22.75% vs 14-15%), NIM (3.37% vs 3.3-3.35%), asset quality (best-in-cycle). Discipline evident (exited ₹10K Cr loss-making account, full repricing done).
1 · Q2 FY27 (Oct 2026)
Corporate loan book recovery from ₹10K Cr exit; expect 12-13% FY-end growth
2 · Q3-Q4 FY27 (Jan-Mar 2027)
₹5,000 Cr equity raise (1-2+ tranches, QIP or public offering), ₹1,000 Cr Tier 2 bonds
3 · Aug-Sep 2026
ECLGS disbursement completion (₹1,800 Cr pending, target 95-100%), ECL provisioning done
Capital raise (₹5K Cr) dilution in Q3-Q4 also headwind.